Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Enwave Corp V.ENW

Alternate Symbol(s):  NWVCF

EnWave Corporation is an applied dehydration technology company. The Company’s principal business is the licensing of its intellectual property through royalty-bearing agreements and the design, construction, marketing, and sales of vacuum-microwave dehydration machinery for the food, cannabis and biomaterial industries. It has entered into 54 royalty-bearing commercial licenses with and sold REV equipment to a diverse portfolio of companies operating in over 23 different countries on five continents. It also operates REVworx, a toll processing facility located in Delta, British Columbia that offers vacuum-microwave contract manufacturing services. The REVworx facility houses both a batch 10 kilowatt (kW) and 60 kW continuous vacuum-microwave line to accelerate the commercialization of products made with the Company’s patented technology. The Company has two primary commercial scale technologies, nutraREV, a drum-based system, and quantaREV, a tray-based system.


TSXV:ENW - Post by User

Bullboard Posts
Post by WallaceWilliamon Jul 28, 2016 9:36am
161 Views
Post# 25091250

This is It... Global Pharmaceutical Business Development

This is It... Global Pharmaceutical Business Development Enwave announces today that it has hired Dr. Richard Mitchell, a seasoned pharmaceutical industry professional with over three decades of experience in various management and business development roles. He has accepted the role of Senior Vice President, Pharmaceutical Business Development at EnWave Corporation.

Dr. Mitchell was formerly the Director of Business Development at Fred Hutchinson Cancer Research Center after holding strategic positions in many well-known pharmaceutical and technology companies, including Nastech Pharmaceutical, Adnavance Technologies and Shoreline Community College, MDS Pharma Services, among others. Dr. Mitchell brings a scientific background paired with a strong business acumen to forge successful relationships within the biotech arena. With this extensive industry knowledge, Dr. Mitchell will join the EnWave management team and assume responsibility for expanding the presence of EnWave's REV™ technology in the biotech and pharmaceutical sectors by drawing on his experience as an accomplished pharmaceutical industry executive.


Bullboard Posts